Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Best and Worst from Shareholder Meeting re to 350 Millions

From my notes at SHM. Lechrone said "about $350 million LESS EXPENSES was paid to PTSC". No mention as to the AMOUNT of the expenses. Doc.

Share
New Message
Please login to post a reply